Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Silexion Therapeutics Corp (SLXN) had Current Ratio of 1.00 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.73M |
|
-- |
|
-- |
|
$2.75M |
|
$-2.75M |
|
$0.02M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.75M |
|
$-2.75M |
|
3.23M |
|
3.23M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$4.07M |
|
$0.02M |
|
$0.54M |
|
$4.60M |
|
$4.06M |
|
-- |
|
$0.25M |
|
$4.31M |
|
$0.29M |
|
$0.29M |
|
$0.29M |
|
3.40M |
|
| Cash Flow Statement Financials | |
$-3.65M |
|
$0.00M |
|
$0.08M |
|
$6.08M |
|
$2.50M |
|
$-3.58M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
1.00 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-939.16% |
|
-939.17% |
|
-59.39% |
|
-939.18% |
|
$0.09 |
|
$-1.13 |
|
$-1.13 |
|